Bright Minds Biosciences: Promising Catalysts Despite The FDA Setback
Bright Minds Biosciences: Downgrade To 'Hold' On BMB-101 Setback DEE And Progression Into PWS
FDA puts partial hold on Bright Minds’ Phase II seizure study
Baird Maintains Outperform on Bright Minds Biosciences, Lowers Price Target to $107
BTIG Maintains Buy on Bright Minds Biosciences, Lowers Price Target to $37
Bright Minds Biosciences Faces Partial FDA Clinical Hold on BMB-101 Phase 2 Epilepsy Study
Bright Minds stock plunges as FDA halts epilepsy trial
Bright Minds Biosciences' BMB-101 Phase 2 Trial Placed on FDA Partial Hold
Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies
FDA Setback Clouds Timeline For Bright Minds Biosciences' Pediatric Epilepsy Trials
Bright Minds Biosciences' Investigational New Drug Application For Developmental And Epileptic Encephalopathies And Related Protocol BMB-101-105 Has Been Placed On Partial Clinical Hold Following FDA Review
Wolfe Research Initiates Coverage On Bright Minds Biosciences with Outperform Rating, Announces Price Target of $150
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
Bright Minds Biosciences to Present at Upcoming Conferences
What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?
Wall Street Analysts See a 97.01% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?
HC Wainwright & Co. Reiterates Buy on Bright Minds Biosciences, Maintains $145 Price Target
BTIG Reiterates Buy on Bright Minds Biosciences, Maintains $147 Price Target
Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 97.4%: Read This Before Placing a Bet
Bright Minds: BMB-101 Takes Center Stage Ahead Of Phase 3 Pivotal Trials
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.